Organogenesis
This article was originally published in The Gray Sheet
Executive Summary
Philip Laughlin, president and chief operating officer, takes on the title of CEO Jan. 1, following the retirement of Herbert Stein as CEO and chairman. Stein will continue to serve as chairman emeritus while board member Albert Erani will become chairman